Quest Introduces First-To-Market Consumer-Initiated Blood Test for Alzheimer’s Disease Risk Assessment on questhealth.com

AD-Detectâ„¢ Test for Alzheimer’s Disease is the first blood-based biomarker test for assessing beta amyloid protein, a recognized marker of Alzheimer’s disease, available for consumer purchase to help individuals identify their risk of developing Alzheimer’s disease Physician oversight…